DJIA 15,387.58 52.30 0.34%
NASDAQ 3,502.12 5.69 0.16%
S&P 500 1,669.16 2.87 0.17%

company name or ticker

Ariad Pharmaceuticals Inc. Presents at UBS Global Healthcare Conference, May-20-2013 08:30 AM

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Cancer research is big business, and it pays to know where research dollars are headed.

3 Companies That Put the "Tech" in "Biotech"

From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."

Ariad Stock Falls On Unusually High Volume (ARIA)

Benzinga's Top Pre-Market Losers

ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting

10 ASCO '13 Abstracts You Can Read Right Now

ARIAD Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcr

ARIAD Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)

2 Biotech Companies With Strong Product Launches To Monitor

ARIAD to Present at UBS Global Healthcare Conference

See More Articles...